Yavas, G. Et Al. 2013. Does spironolactone ameliorate trastuzumab-induced cardiac toxicity?. MEDICAL HYPOTHESES , vol.81, no.2 , 231-234.

Yavas, G., Elsurer, R., YAVAŞ, C., Elsurer, C., & Ata, O., (2013). Does spironolactone ameliorate trastuzumab-induced cardiac toxicity?. MEDICAL HYPOTHESES , vol.81, no.2, 231-234.

Yavas, Guler Et Al. "Does spironolactone ameliorate trastuzumab-induced cardiac toxicity?," MEDICAL HYPOTHESES , vol.81, no.2, 231-234, 2013

Yavas, Guler Et Al. "Does spironolactone ameliorate trastuzumab-induced cardiac toxicity?." MEDICAL HYPOTHESES , vol.81, no.2, pp.231-234, 2013

Yavas, G. Et Al. (2013) . "Does spironolactone ameliorate trastuzumab-induced cardiac toxicity?." MEDICAL HYPOTHESES , vol.81, no.2, pp.231-234.

@article{article, author={Guler Yavas Et Al. }, title={Does spironolactone ameliorate trastuzumab-induced cardiac toxicity?}, journal={MEDICAL HYPOTHESES}, year=2013, pages={231-234} }